SYH2053 Injection

SYH2053 · CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SYH2053 Injection, covering 2026-03-19 to 2026-03-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the SYH2053 Injection in Patients With Heterozygous Familial Hypercholesterolemia (HeFH) [Phase 3]

See pricing